Call for Working Group Members
Summit4CI Highly Qualified Personnel (HQP) Working Group

BioCanRx’s Summit for Cancer Immunotherapy (Summit4CI), taking place November 19-21, 2022 in Montreal, Quebec will showcase innovative research in cancer immunotherapy, featuring national and internationally renowned scientists. The event will bring together the Canadian cancer research community with representation from academia, government, industry, charities and patient advocacy groups to foster multi-disciplinary collaboration. The Summit will also deliver meaningful training activities for highly qualified personnel (HQP). To ensure that training activities meet the needs of HQP, BioCanRx will assemble a HQP Working Group to provide input, direction, and assist in delivering Summit training and networking activities.

Eligibility

BioCanRx is seeking current HQP from the network to participate on this Working Group. HQP includes undergraduate students, graduate students, post-doctoral fellows, research associates, technical and clinical research staff. Efforts will be made to ensure that committee composition represents all of Canada, disciplines/core areas of BioCanRx’s mandate, and types of HQP.

Responsibilities

The Working group will meet approximately monthly via teleconference and once in person at the Summit4CI 2022. The main function of the Working Group shall be to provide input on and deliver HQP training activities at the Summit4CI 2022. Specific responsibilities include:

  1. Provide input on topics for workshops and seminars;
  2. Assist in the delivery of training activities at the Summit4CI;
  3. Evaluate and rank HQP awards competitions for the Summit4CI;
  4. Review the Training activities and make recommendations for improvements.

Application

To apply to become a member of the HQP Working Group please:

  • Complete the application form Download
  • Attach a copy of your CV

Statement on Equity, Diversity and Inclusion

Equity, Diversity and Inclusion (EDI) strengthen the scientific community and the quality, social relevance and impact of research. Sound equity, diversity and inclusion practices increase access to the largest pool of qualified potential participants, enhance the integrity of a program’s application and selection processes, strengthen the research outputs, and increase the overall excellence of research. BioCanRx’s programs and peer review system are intended to ensure fair treatment of all applicants. BioCanRx is committed to implementing policies, processes and initiatives to identify and mitigate barriers and biases that may exist within its own programs and systems, and to work collaboratively with other stakeholders, when appropriate, to do the same.

Questions?

Please contact Sarah Ivanco, Manager of EDI and Training Programs at [email protected], or 905-869-0903.